In This SectionTexas Health Research & Education Institute
Disease or Condition
A Complicated Skin and Soft-Tissue Infection Patient Registry
The purpose of this study is to learn how to best treat diabetic foot infections and surgical site infections. Patients who consent to participate in the registry will be enrolled within 24 hours of initial IV antibiotic therapy for treatment of one or more infection types. Sites will treat patients according to their usual clinical practice. Patients will be asked to complete a short questionnaire on their quality of life and will be followed by the researcher until 30 days after they leave the hospital.
Patients hospitalized with a diagnosis of either Diabetic foot infection (DFI) or Surgical site infection (SSI).
Patients who receive IV antibiotic therapy as a primary treatment for the infection.
Patients who are deemed to be cognitive and capable and to provide informed consent.
Male and female patients aged 18 or older.
Patients with an expected inpatient hospital stay of at least 48 hours for treatment of the study infection.
Patients with a diagnosis at the index infection site of necrotizing soft tissue infection, burn, gangrene, decubitus ulcer, animal or human bites, known or suspected osteomyelitis, or mediastinitis.
Patients for whom amputation or a complete resection of the infection site is a planned component of treatment.
Patients who are pregnant.
Patients simultaneously participating in any interventional clinical trial.
Patients with any other known or suspected condition that may jeopardize adherence to registry protocol requirements.
Patients who are employees of the investigator or study hospital.